Patents by Inventor Hiroaki Yajima

Hiroaki Yajima has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100080862
    Abstract: It is intended to provide compositions and foods for use in the treatment, prophylaxis, or amelioration of diseases or symptoms which can be treated, prevented or ameliorated by activating PPAR, in particular, insulin resistant diabetes and hyperlipidemia. Namely, medicinal compositions usable in treating, preventing or improving diseases or symptoms which can be treated, prevented or ameliorated by activation PPAR which contain humulones, isohumulones or lupulones or pharmaceutically acceptable salts or solvates thereof.
    Type: Application
    Filed: September 10, 2009
    Publication date: April 1, 2010
    Inventors: Hiroaki YAJIMA, Yutaka Miura, Daisuke Fujiwara, Hideharu Odai, Keiji Kondo, Hajime Nozawa
  • Patent number: 7195915
    Abstract: Protein synthesis inhibitor resistance genes (typified by a cycloheximide resistance gene) are capable of imparting resistance to a protein synthesis inhibitor (typified by cycloheximide) to animal cells sensitive to the inhibitor. The genes have a sequence mutated by substitution in a gene encoding a ribosome-constituting protein derived from an animal. The genes may be placed in recombinant vectors, including expression vectors containing the gene together with a foreign protein structural gene.
    Type: Grant
    Filed: November 23, 2005
    Date of Patent: March 27, 2007
    Assignee: Kirin Beer Kabushiki Kaisha
    Inventors: Elisa Misawa, Hiroaki Yajima, Keiji Kondo
  • Publication number: 20060233902
    Abstract: It is intended to provide compositions and foods for use in the treatment, prophylaxis, or amelioration of diseases or symptoms which can be treated, prevented or ameliorated by activating PPAR, in particular, insulin resistant diabetes and hyperlipidemia. Namely, medicinal compositions usable in treating, preventing or improving diseases or symptoms which can be treated, prevented or ameliorated by activation PPAR which contain humulones, isohumulones or lupulones or pharmaceutically acceptable salts or solvates thereof.
    Type: Application
    Filed: February 14, 2003
    Publication date: October 19, 2006
    Applicant: Kirin Beer Kabushiki Kaisha
    Inventors: Hiroaki Yajima, Yutaka Miura, Daisuke Fujiwara, Hideharu Odai, Keiji Kondo, Hajime Nozawa
  • Publication number: 20060147568
    Abstract: According to the present invention, there is provided a blood pressure-lowering agent, a vascular flexibility-ameliorating agent and foods having these functions imparted thereto, which are comprising isohumulones or a hop extract and/or an isomerized hop extract as an active ingredient.
    Type: Application
    Filed: January 16, 2004
    Publication date: July 6, 2006
    Inventors: Akihiko Takeuchi, Taku Sato, Hiroaki Yajima, Yutaka Miura, Keiji Kondo, Aruto Yoshida, Kiyoshi Yoshida, Junko Tomita
  • Patent number: 7064194
    Abstract: Protein synthesis inhibitor resistance genes (typified by a cycloheximide resistance gene) are capable of imparting resistance to a protein synthesis inhibitor (typified by cycloheximide) to animal cells sensitive to the inhibitor. The genes have a sequence mutated by substitution in a gene encoding a ribosome-constituting protein derived from an animal. The genes may be placed in recombinant vectors, including expression vectors containing the gene together with a foreign protein structural gene.
    Type: Grant
    Filed: March 8, 2002
    Date of Patent: June 20, 2006
    Assignee: Kirin Beer Kabushiki Kaisha
    Inventors: Elisa Misawa, Hiroaki Yajima, Keiji Kondo
  • Publication number: 20060078992
    Abstract: Protein synthesis inhibitor resistance genes (typified by a cycloheximide resistance gene) are capable of imparting resistance to a protein synthesis inhibitor (typified by cycloheximide) to animal cells sensitive to the inhibitor. The genes have a sequence mutated by substitution in a gene encoding a ribosome-constituting protein derived from an animal. The genes may be placed in recombinant vectors, including expression vectors containing the gene together with a foreign protein structural gene.
    Type: Application
    Filed: November 23, 2005
    Publication date: April 13, 2006
    Inventors: Elisa Misawa, Hiroaki Yajima, Keiji Kondo
  • Publication number: 20040242512
    Abstract: The present invention is intended to provide a technique for selecting cells, into which a gene has been transfected in a stable state, by using a novel drug resistant gene as a selection marker, and a technique for obtaining cells in which a gene is highly expressed.
    Type: Application
    Filed: September 8, 2003
    Publication date: December 2, 2004
    Inventors: Elisa Misawa, Hiroaki Yajima, Keiji Kondo
  • Patent number: 4747116
    Abstract: A sync signal detecting device includes a circuit for generating a sync signal pattern corresponding to an expected sync signal pattern contained in a digital signal, a circuit for comparing the digital signal with the sync signal pattern to detect a sync signal in the digital signal, a circuit for detecting errors in the digital signal, and a counter for counting the errors thus detected. A sync detection signal is outputted when, where no error is detected, the sync pattern is detected, and when, where errors are detected, the number of errors detected is a predetermined value or less and the part of the digital signal which is not coincident with the sync signal pattern is the part where the errors have been detected.
    Type: Grant
    Filed: March 21, 1986
    Date of Patent: May 24, 1988
    Assignee: Pioneer Electric Corporation
    Inventors: Hiroaki Yajima, Youichirou Tsuda